Loading news...
Agilent Technologies (NYSE: A - Get Free Report) and PURE Bioscience (OTCMKTS:PURE - Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, profitability, risk, earnings, valuation and institutional ownership. Risk and Volatility Agilent Technologies has a beta
PURE HomeRiver will operate as the nation's largest third-party single-family rental (SFR) property management company LOS GATOS, Calif., Jan. 22, 2026 /PRNewswire/ -- PURE Property Management and HomeRiver Group today announced their merger, operating as PURE HomeRiver.
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2025. Summary of Results of Operations – Fiscal First Quarter Net product sales were $707,000 and $555,000 for the fiscal first quarter ended October 31, 2025 and 2024, respectively. The increase of $152,000 was attributable to increa.
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE” or the “Company”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today announced that the Company has appointed Jeff Kitchell as President, in addition to his ongoing responsibilities as Corporate Secretary, and Dolana Blount as Vice President of Operations, in addition to her ongoing responsibilities as Vice President of Regulatory Affairs, in each case, effective as of November 17.
Strategic combination positions combined company to capture AI infrastructure demand at scale Movano (Nasdaq: MOVE) shareholders gain exposure to rapidly emerging AI infrastructure pure play platform with differentiated product offering, a growing sales pipeline with attractive credit quality, leadership experienced in large-scale distributed computing and software development, and disciplined capital allocation Merger exchange ratio based upon a Movano per share value of $6.25 Corvex, together with Movano, raised an aggregate of $40.0 million from concurrent private placement financings Taking into account concurrent financings, Corvex shareholders to receive 46.6 million shares of Movano stock Movano Health to resume process to market its medical device operations, including FDA-cleared EvieMED Ring and proprietary mmWave RF technology for cuffless blood pressure and noninvasive glucose monitoring PLEASANTON, Calif. and ARLINGTON, Va.
PURE Bioscience (OTCMKTS:PURE - Get Free Report) saw a large decline in short interest during the month of October. As of October 15th, there was short interest totaling 2,900 shares, a decline of 29.3% from the September 30th total of 4,100 shares. Based on an average daily trading volume, of 45,400 shares, the short-interest ratio
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal year ended July 31, 2025. Summary of Results – Year-End Operations Net product sales were $2,198,000 and $1,955,000 for the fiscal years ended July 31, 2025 and 2024, respectively. The $243,000 increase was attributable to increased sales across our end-user and dis.
BOSTON , Aug. 05, 2025 (GLOBE NEWSWIRE) -- Duck Creek Technologies, the global intelligent solutions provider defining the future of property and casualty (P&C) and general insurance, today announced PURE Insurance, the member-owned insurer designed for successful, responsible families, has upgraded to the latest version of Duck Creek Billing. By leveraging Duck Creek Billing, PURE gains enhanced stability, performance, and access to the latest billing innovations allowing for greater customization and automated financial operations.
EL CAJON, Calif.--(BUSINESS WIRE)---- $PURE #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial and Bonsai (“Bonsai”), has entered into a multi-year distribution agreement for the purchase and sale of SDC products under special terms and conditions. This agreement authorizes Bonsai as an official distributor of PURE's EPA-registered disinfectants, expanding market access to PURE's revolutionary Silver Dihydr.
New Pure Storage platform innovations help customers solve data management challenges today and in the future LAS VEGAS , June 18, 2025 /PRNewswire/ -- Pure//Accelerate – Pure Storage® (NYSE: PSTG), the IT pioneer that delivers the world's most advanced data storage technology and services, today introduced the Enterprise Data Cloud (EDC), a bold new standard in data and storage management simplicity that enables organizations to focus on business outcomes, not infrastructure. Fueled by AI, data volumes are rising and business demands are evolving faster than ever.
New Pure Storage FlashArray and FlashBlade offerings support the most massive demands for increasingly intensive workloads LAS VEGAS , June 18, 2025 /PRNewswire/ -- Pure//Accelerate -- Pure Storage® (NYSE: PSTG), the IT pioneer that delivers the world's most advanced data storage technology and services, today announced an expansion of its next-generation storage products designed for the most demanding, high-performance workloads. "In an era where data is king and IT complexity remains a major hurdle to accessing and using data for optimal business value, Pure Storage is once again redefining what's possible for customers," said John Colgrove (Coz), Founder and Chief Visionary at Pure Storage.
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal third quarter ended April 30, 2025. Summary of Results of Operations – Fiscal Third Quarter Net product sales were $489,000 and $440,000 for the fiscal third quarter ended April 30, 2025 and 2024, respectively. The increase of $49,000 was attributable to increased s.
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, is proud to announce an innovative application method for membrane treatment in the dairy and beverage industry using our flagship product, PURE® Hard Surface. This groundbreaking solution addresses common membrane fouling and sanitization challenges, delivering outstanding results that enable operators to restor.
SANTA CLARA, Calif. , May 27, 2025 /PRNewswire/ -- Pure Storage® (NYSE: PSTG), the IT pioneer that delivers the world's most advanced data storage technology and services, today announced a collaboration with SK hynix Inc, a pioneer in the global AI memory industry, to deliver state-of-the-art QLC flash storage products that meet the high-capacity, energy efficient requirements for data-intensive hyperscaler environments.
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Hydrite Chemical Company (“Hydrite”) have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to announce the signing of a strategic distribution agreement with Hydrite, a top-tier provider of complete solutions for.
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and branded by Greenville (“bbG”), is excited to announce the official start of an extensive rebranding campaign to renew its corporate vision. This rebranding initiative aims to strengthen the Company's identity and culture in the market and to better reflect its commitment to cutting-edge scientific advancement.
EL CAJON, Calif.--(BUSINESS WIRE)-- #Antimicrobial--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, today reported financial results for the fiscal first quarter ended October 31, 2024. Summary of Results – Fiscal First Quarter Operations Net product sales were $555,000 and $718,000 for the fiscal first quarters ended October 31, 2024 and 2023, respectively. The decrease of $163,000 was attributable to budgetar.
EL CAJON, Calif.--(BUSINESS WIRE)-- #AFCO--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and AFCO, a Zep Company (“AFCO”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is excited to announce the signing of a strategic distribution agreement with AFCO, a leading provider of cleaning and sanitation solutions.
EL CAJON, Calif.--(BUSINESS WIRE)-- #AALAS--PURE Bioscience, Inc. (OTCQB: PURE) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate (SDC) antimicrobial, and Quip Laboratories, Inc. (“Quip Labs”), have entered into a multi-year distribution agreement for the purchase and selling of SDC products under special terms and conditions. PURE is pleased to announce the signing of a strategic distribution agreement with Quip Labs, a distinguished leader in solutions for th.